← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phase V Pharmaceuticals, Inc.
Silver Spring, MD
$941,224
Total funding
2
Grants
Funding over time
peak $735.6K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$941,224 · 2
By mechanism
R44$941,224 · 2
Investigators at Phase V Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Baclofen formulation for spasticity with dysphagia$635,572
R44 · FY2005 · HD
Baclofen formulation for spasticity with dysphagia$105,652
R44 · FY2006 · HD
Tizanidine formulation for spasticity with dysphagia$100,000
R44 · FY2006 · HD
Baclofen formulation for spasticity with dysphagia$100,000
R44 · FY2005 · HD